Monotherapy with the once-weekly GLP-1 analogue dulaglutide for 12 weeks in patients with Type 2 diabetes: dose-dependent effects on glycaemic control in a randomized, double-blind, placebo-controlled study
2012 ◽
Vol 29
(10)
◽
pp. 1260-1267
◽
Keyword(s):
Keyword(s):
2012 ◽
Vol 14
(6)
◽
pp. 565-574
◽
Keyword(s):
2010 ◽
Vol 12
(3)
◽
pp. 246-251
◽
Keyword(s):
Keyword(s):
2020 ◽
Keyword(s):
2020 ◽
Keyword(s):
2020 ◽
Vol 22
(6)
◽
pp. 938-946
◽
2019 ◽
Vol 43
◽
pp. 283-288
◽
Keyword(s):